November 2022

NEWS & COLUMNS

6-7 NEWS
Amgen buys ChemoCentryx in deal worth $3.7bn; Novo Nordisk pays $1.1bn for Forma Therapeutics

8-9 NEWS
Novartis’ Pluvicto recommended by CHMP; NHS England launches genetic testing service

10-12 CORONAVIRUS NEWS
New study on immune responses to COVID-19 vaccines; Act-Accelerator outlines long-term COVID-19 plans;

13 DARWIN'S MEDICINE
C-Suite keystones - which type of CEO is yours?

14 WE'VE GOT TALENT
The healthcare communications sector has a lot to offer prospective employees, but in today’s job market, how can agencies attract and retain talent?

15 PHARMA STRATEGIST’S BLOG
Approaches to portfolio strategy have become more holistic across the healthcare industry but what are the benefits for business?

FEATURES

16-17 THE ROLE OF THE PATIENT VOICE IN DIGITAL TRANSFORMATION
Why the real drivers of change in digital transformation, the patients themselves, cannot be underestimated or left behind

18-19 HOW TELEMONITORING CAN REVOLUTIONISE THE WAY WE TREAT PATIENTS
As further pressure is placed on NHS diagnostics, telemonitoring can offer efficency and improved outcomes for patients and HCPs

22-23 REIMAGINING STRATEGY DEVELOPMENT FOR A HYBRID WORKFORCE
To keep up with the ever-changing landscape of healthcare communications, the tools needed for strategy development have to adapt

24-26 OMNICHANNEL ENGAGEMENT - GLOBAL LEADERS IN DIGITAL CHANNELS
Exploring why UK field teams are global leaders in digital channels is key to better understanding the changes in omnichannel engagement

16-17 THE PATIENT VOICE AND DIGITAL TRANSFORMATION